semaglutide clinical trials near me Semaglutide: The Drug of Today and a Steppingstone to Tomorrow Weight-loss drug semaglutide reduces heavy
Description
JAMA 2024;332(12):970978
MASLD Risk Extends Beyond Obesity New data show lean individuals with #MASLD face higher risks of liver complications, cancer, and mortality than those with obesitychallenging BMI-based screening and reinforcing the need for earlier, metabolism-focused liver diagnostics
This suggests a potential direct effect on neuroinflammation, implicated in various neurodegenerative disorders
Known hypersensitivity to semaglutide or any component
5c, Supplementary Fig
